{"Q": 1, "answer": "no", "rationale": "The segment describes a vaccine deal but contains no intensifier or comparative modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_4624", "batch_size": 200, "batch_pos": 15, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 2, "answer": "no", "rationale": "The segment does not contain any high-potency verbs, potent metaphors, superlatives + harm nouns, intensifiers + harm nouns, or critical alert phrases.", "method": "llm_batch", "batch_id": "batch_2_4248", "batch_size": 200, "batch_pos": 2, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 3, "answer": "no", "rationale": "No moderate verb or scale related to outbreak impact.", "method": "llm_batch", "batch_id": "batch_3_10644", "batch_size": 200, "batch_pos": 144, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a question.", "method": "llm_batch", "batch_id": "batch_4_19804", "batch_size": 200, "batch_pos": 139, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 5, "answer": "no", "rationale": "The segment reports details of a deal neutrally without explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_14232", "batch_size": 200, "batch_pos": 136, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 6, "answer": "no", "rationale": "No minimiser or scale contrast found.", "method": "llm_batch", "batch_id": "batch_6_3320", "batch_size": 200, "batch_pos": 107, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_3444", "batch_size": 200, "batch_pos": 82, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 8, "answer": "yes", "rationale": "Describes securing vaccine doses (preparedness/resource acquisition) ('deal secures up to 665,000 doses... includes an option for a further 40 million vaccines') without explicit calming keywords.", "method": "llm_batch", "batch_id": "batch_8_17012", "batch_size": 200, "batch_pos": 113, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
